{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:31Z","timestamp":1789039771788,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The optimal time cut-off for appropriate antibiotic therapy (AAT) in methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA) bacteremia remains uncertain. We assessed the effects of time to AAT on 30-day in-hospital mortality in patients with MRSA bacteremia who received glycopeptides as initial therapy, and applied landmark analyses to adjust for immortal-time bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of adults with MRSA bacteremia who received an initial course of glycopeptide therapy at two university-affiliated hospitals between 2018 and 2023. Multivariable logistic regression was used to identify covariates. These covariates were then included in six separate landmark models that assessed the effect of AAT within pre-specified cut-off time of 3, 6, 12, 24, 48, and 72\u2009h after the index blood culture collection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 220 patients, osteoarticular infections were the focus of bacteremia in 25.5%, and septic shock occurred as a complication in 28.2%; 30-day in-hospital mortality was 24.1%. Vancomycin was administered as initial therapy in 63.2% of patients, and the median time to glycopeptide initiation was 36\u2009h (interquartile range, 19\u201367.5). Metastatic solid tumor, initial septic shock, pneumonia, and unknown focus were independent risk factors for death according to multivariable analysis. After covariate adjustment, glycopeptide therapy administered within any of the six pre-defined cut-off time was not significantly associated with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No significant time cut-off for glycopeptide initiation was associated with increased mortality. In patients without septic shock or other mortality-related risk factors, a modest delay in AAT may have slight effect on outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12040-9","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:59:32Z","timestamp":1763546372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Tae-Hoon","family":"No","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jun","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"8","key":"12040_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","volume":"28","author":"AD Bai","year":"2022","unstructured":"Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, et al. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(8):1076\u201384. https:\/\/doi.org\/10.1016\/j.cmi.2022.03.015.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"12040_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","volume":"92","author":"YP Chong","year":"2013","unstructured":"Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Park KH, et al. Persistent staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Med (baltim). 2013;92(2):98\u2013108. https:\/\/doi.org\/10.1097\/MD.0b013e318289ff1e.","journal-title":"Med (baltim)"},{"issue":"2","key":"12040_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/cmr.05022-11","volume":"25","author":"VH Sj","year":"2012","unstructured":"Sj VH, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362\u201386. https:\/\/doi.org\/10.1128\/cmr.05022-11.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"12040_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jac\/dkh366","volume":"54","author":"SH Kim","year":"2004","unstructured":"Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. The J Antimicrob Chemother. 2004;54(2):489\u201397. https:\/\/doi.org\/10.1093\/jac\/dkh366.","journal-title":"The J Antimicrob Chemother"},{"issue":"3","key":"12040_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jac\/dkl006","volume":"57","author":"CT Fang","year":"2006","unstructured":"Fang CT, Shau WY, Hsueh PR, Chen YC, Wang JT, Hung CC, et al. Early empirical glycopeptide therapy for patients with methicillin-resistant staphylococcus aureus bacteraemia: impact on the outcome. The J Antimicrob Chemother. 2006;57(3):511\u201319. https:\/\/doi.org\/10.1093\/jac\/dkl006.","journal-title":"The J Antimicrob Chemother"},{"issue":"8","key":"12040_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/01.Ccm.0000227655.41566.3e","volume":"34","author":"GE Schramm","year":"2006","unstructured":"Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med. 2006;34(8):2069\u201374. https:\/\/doi.org\/10.1097\/01.Ccm.0000227655.41566.3e.","journal-title":"Crit Care Med"},{"issue":"2","key":"12040_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2008.11.003","volume":"58","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2009","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Mill\u00e1n AB, Dom\u00ednguez MA, Borraz C, Gonz\u00e1lez MP, Almirante B, et al. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant staphylococcus aureus. The J Infect. 2009;58(2):131\u201337. https:\/\/doi.org\/10.1016\/j.jinf.2008.11.003.","journal-title":"The J Infect"},{"issue":"6","key":"12040_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1469-0691.2009.02934.x","volume":"16","author":"D Marchaim","year":"2010","unstructured":"Marchaim D, Kaye KS, Fowler VG, Anderson DJ, Chawla V, Golan Y, et al. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16(6):747\u201352. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02934.x.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"12040_CR9","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1093\/jac\/dkq373","volume":"65","author":"M Paul","year":"2010","unstructured":"Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant staphylococcus aureus bacteraemia. The J Antimicrob Chemother. 2010;65(12):2658\u201365. https:\/\/doi.org\/10.1093\/jac\/dkq373.","journal-title":"The J Antimicrob Chemother"},{"key":"12040_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12879-016-1650-8","volume":"16","author":"YK Yoon","year":"2016","unstructured":"Yoon YK, Park DW, Sohn JW, Kim HY, Kim YS, Lee CS, et al. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infect Dis. 2016;16:331. https:\/\/doi.org\/10.1186\/s12879-016-1650-8.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12040_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/ccm.0000000000004212","volume":"48","author":"KA Corl","year":"2020","unstructured":"Corl KA, Zeba F, Caffrey AR, Hermenau M, Lopes V, Phillips G, et al. Delay in antibiotic administration is associated with mortality among septic shock patients with staphylococcus aureus bacteremia. Crit Care Med. 2020;48(4):525\u201332. https:\/\/doi.org\/10.1097\/ccm.0000000000004212.","journal-title":"Crit Care Med"},{"issue":"2","key":"12040_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in us hospitals. Lancet Infect Dis. 2021;21(2):241\u201351. https:\/\/doi.org\/10.1016\/s1473-3099(20)30477-1.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"12040_CR13","doi-asserted-by":"publisher","first-page":"e2249353","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma T, Chihara S, Costin B, Treggiari MM, Bartz RR, Raghunathan K, et al. Association of appropriate empirical antimicrobial therapy with In-hospital mortality in patients with bloodstream infections in the us. JAMA Netw Open. 2023;6(1):e2249353. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49353.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"12040_CR14","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1086\/375057","volume":"36","author":"TP Lodise","year":"2003","unstructured":"Lodise TP, Ps M, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36(11):1418\u201323. https:\/\/doi.org\/10.1086\/375057.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"12040_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cid\/ciac727","volume":"76","author":"J Van Heuverswyn","year":"2023","unstructured":"Van Heuverswyn J, Valik JK, Desir\u00e9e van der Werff S, Hedberg P, Giske C, Naucl\u00e9r P. Association between Time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: a retrospective cohort study. Clin Infect Dis. 2023;76(3):469\u201378. https:\/\/doi.org\/10.1093\/cid\/ciac727.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"12040_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/cid\/ciad450","volume":"77","author":"TR Pak","year":"2023","unstructured":"Pak TR, Young J, McKenna CS, Agan A, DelloStritto L, Filbin MR, et al. Risk of misleading conclusions in observational studies of time-to-antibiotics and mortality in suspected sepsis. Clin Infect Dis. 2023;77(11):1534\u201343. https:\/\/doi.org\/10.1093\/cid\/ciad450.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12040_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jmii.2023.07.010","volume":"56","author":"SH Kim","year":"2023","unstructured":"Kim SH, Jeon M, Jang S, Mun SJ. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: the importance of treatment response rather than bacteremia duration. J Microbiol Immunol Infect. 2023;56(5):1007\u201315. https:\/\/doi.org\/10.1016\/j.jmii.2023.07.010.","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"12040_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2021.10.001","volume":"83","author":"R Willekens","year":"2021","unstructured":"Willekens R, Puig-Asensio M, Suanzes P, Fern\u00e1ndez-Hidalgo N, Larrosa MN, Gonz\u00e1lez-L\u00f3pez JJ, et al. Mortality in staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study. The J Infect. 2021;83(6):656\u201363. https:\/\/doi.org\/10.1016\/j.jinf.2021.10.001.","journal-title":"The J Infect"},{"issue":"1","key":"12040_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0924-8579(98)00060-0","volume":"11","author":"JW Chow","year":"1999","unstructured":"Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int. J. Antimicrob. Agents. 1999;11(1):7\u201312. https:\/\/doi.org\/10.1016\/s0924-8579(98)00060-0.","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"12040_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40506-021-00254-9","volume":"13","author":"JM Mylotte","year":"2021","unstructured":"Mylotte JM. Models for assessing severity of illness in patients with bloodstream infection: a narrative review. Curr Treat Options Infect Dis. 2021;13(4):153\u201364. https:\/\/doi.org\/10.1007\/s40506-021-00254-9.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"5","key":"12040_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","volume":"41","author":"RM O\u2019brien","year":"2007","unstructured":"O\u2019brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673\u201390. https:\/\/doi.org\/10.1007\/s11135-006-9018-6.","journal-title":"Qual Quant"},{"issue":"1","key":"12040_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","volume":"115","author":"S Lemeshow","year":"1982","unstructured":"Lemeshow S, Dw H, Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115(1):92\u2013106. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a113284.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"12040_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/cc3000","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care. 2004;8(6):508\u201312. https:\/\/doi.org\/10.1186\/cc3000.","journal-title":"Crit Care"},{"key":"12040_CR24","doi-asserted-by":"publisher","unstructured":"Mylotte JM. High early mortality in patients with staphylococcus aureus bloodstream infection: a call for action. Patient Saf. 2025;7(2). https:\/\/doi.org\/10.33940\/001c.125200.","DOI":"10.33940\/001c.125200"},{"issue":"12","key":"12040_CR25","doi-asserted-by":"publisher","first-page":"ofac653","DOI":"10.1093\/ofid\/ofac653","volume":"9","author":"van der Vaart Tw","year":"2022","unstructured":"van der Vaart Tw, Prins JM, Soetekouw R, van Twillert G, Veenstra J, Herpers BL, et al. All-cause and infection-related mortality in staphylococcus aureus bacteremia, a multicenter prospective cohort study. Open Forum Infect Dis. 2022;9(12):ofac653. https:\/\/doi.org\/10.1093\/ofid\/ofac653.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"12040_CR26","doi-asserted-by":"publisher","first-page":"ofaf338","DOI":"10.1093\/ofid\/ofaf338","volume":"12","author":"S Bae","year":"2025","unstructured":"Bae S, Kook MS, Chang E, Jung J, Kim MJ, Chong YP, et al. Risk and distribution of metastatic infections by primary infection focus in staphylococcus aureus bacteremia. Open Forum Infect Dis. 2025;12(6):ofaf338. https:\/\/doi.org\/10.1093\/ofid\/ofaf338.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"12040_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/cmr.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Vg F, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603\u201361. https:\/\/doi.org\/10.1128\/cmr.00134-14.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"12040_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","volume":"42","author":"M Papadimitriou-Olivgeris","year":"2023","unstructured":"Papadimitriou-Olivgeris M, Caruana G, Senn L, Guery B. Predictors of mortality of staphylococcus aureus bacteremia among patients hospitalized in a Swiss University hospital and the role of early source control; a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2023;42(3):347\u201357. https:\/\/doi.org\/10.1007\/s10096-023-04557-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"12040_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jac\/dkab499","volume":"77","author":"Y Hanai","year":"2022","unstructured":"Hanai Y, Takahashi Y, Niwa T, Mayumi T, Hamada Y, Kimura T, et al. Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring. The J Antimicrob Chemother. 2022;77(4):869\u201379. https:\/\/doi.org\/10.1093\/jac\/dkab499.","journal-title":"The J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12040-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:11:46Z","timestamp":1781615506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12040"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12040-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Inje University Busan Paik Hospital IRB and the Inje University Haeundae Paik Hospital IRB, and the requirement for consent was waived (IRB numbers: BPIRB 2025\u201301-013 and HPIRB 2025\u201301-005). The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1614"}}